NDC 73625-111

CAMZYOS

Mavacamten

CAMZYOS is a Oral Capsule, Gelatin Coated in the Cellular Therapy category. It is labeled and distributed by Myokardia, Inc.. The primary component is Mavacamten.

Product ID73625-111_175808e7-ba8b-49b6-bc26-3de9d98ecfd4
NDC73625-111
Product TypeCellular Therapy
Proprietary NameCAMZYOS
Generic NameMavacamten
Dosage FormCapsule, Gelatin Coated
Route of AdministrationORAL
Marketing Start Date2022-04-28
Marketing CategoryNDA /
Application NumberNDA214998
Labeler NameMyokardia, Inc.
Substance NameMAVACAMTEN
Active Ingredient Strength3 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 73625-111-11

30 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (73625-111-11)
Marketing Start Date2022-04-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "CAMZYOS" or generic name "Mavacamten"

NDCBrand NameGeneric Name
73625-111CAMZYOSmavacamten
73625-112CAMZYOSmavacamten
73625-113CAMZYOSmavacamten
73625-114CAMZYOSmavacamten

Trademark Results [CAMZYOS]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CAMZYOS
CAMZYOS
98478203 not registered Live/Pending
MyoKardia, Inc.
2024-04-01
CAMZYOS
CAMZYOS
97539194 not registered Live/Pending
MyoKardia, Inc.
2022-08-08
CAMZYOS
CAMZYOS
90463748 not registered Live/Pending
MyoKardia, Inc.
2021-01-13
CAMZYOS
CAMZYOS
88693134 not registered Live/Pending
MyoKardia, Inc.
2019-11-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.